Cite
Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
MLA
Kim, Namkyung, et al. “Hispidulin Alleviates Imiquimod-Induced Psoriasis-like Skin Inflammation by Inhibiting Splenic Th1/Th17 Cell Population and Keratinocyte Activation.” International Immunopharmacology, vol. 87, Oct. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.intimp.2020.106767.
APA
Kim, N., Lee, S., Kang, J., Choi, Y.-A., Lee, B., Kwon, T. K., Jang, Y. H., & Kim, S.-H. (2020). Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation. International Immunopharmacology, 87, N.PAG. https://doi.org/10.1016/j.intimp.2020.106767
Chicago
Kim, Namkyung, Soyoung Lee, Jinjoo Kang, Young-Ae Choi, Byungheon Lee, Taeg Kyu Kwon, Yong Hyun Jang, and Sang-Hyun Kim. 2020. “Hispidulin Alleviates Imiquimod-Induced Psoriasis-like Skin Inflammation by Inhibiting Splenic Th1/Th17 Cell Population and Keratinocyte Activation.” International Immunopharmacology 87 (October): N.PAG. doi:10.1016/j.intimp.2020.106767.